The Tyrosine Phosphatase SHP2: A Key Molecule Linked both Type 2Diabetes and Cancers?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Medicinal Chemistry

• Publication date

  2014-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2161-0444.1000175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance

  2014cited by this paper
• The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK

  2014cited by this paper
• PI3K/AKT Signaling Is Essential for Communication between Tissue-Infiltrating Mast Cells, Macrophages, and Epithelial Cells in Colitis-Induced Cancer

  2013cited by this paper
• Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women.

  2013cited by this paper
• Expression of SHP2 and Related Markers in Non–Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases

  2013cited by this paper
• Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan

  2013cited by this paper
• Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

  2013cited by this paper
• Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK.

  2013cited by this paper
• Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

  2013cited by this paper
• Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

  2013cited by this paper
• A comprehensive survey of Ras mutations in cancer.

  2012cited by this paper
• The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer

  2012cited by this paper
• Involvement of SHP2 in focal adhesion, migration and differentiation of neural stem cells.

  2012cited by this paper
• Dual faces of SH2-containing protein-tyrosine phosphatase Shp2/PTPN11 in tumorigenesis

  2012cited by this paper
• Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer

  2012cited by this paper
• Protein Tyrosine Phosphatase SHP2 Mediates Chronic Insulin-Induced Endothelial Inflammation

  2012cited by this paper
• The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

  2012cited by this paper
• Diabetes and breast cancer risk: a meta-analysis

  2012cited by this paper
• Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.

  2012cited by this paper
• The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer

  2012cited by this paper
• Tyrosine phosphorylation of estradiol receptor by Src regulates its hormone-dependent nuclear export and cell cycle progression in breast cancer cells

  2012cited by this paper
• Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.

  2012cited by this paper
• Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.

  2012cited by this paper
• Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells

  2012cited by this paper
• The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients.

  2012cited by this paper
• Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy

  2012cited by this paper
• Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

  2012cited by this paper
• Capecitabine: An In-vitro Comparison between the Branded Xeloda ® 500 Mg and its Intended Copy Capeda 500 Mg

  2012cited by this paper
• Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta‐analysis of 24 cohort studies

  2012cited by this paper
• RAS Interaction with PI3K: More Than Just Another Effector Pathway.

  2011cited by this paper
• A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.

  2011cited by this paper
• mTORC1 activity as a determinant of cancer risk--rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets.

  2011cited by this paper
• SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver.

  2011cited by this paper
• Diabetes mellitus and the incidence and mortality of colorectal cancer: A meta‐analysis of twenty four cohort studies

  2011cited by this paper
• Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

  2011cited by this paper
• The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes

  2011cited by this paper
• Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes

  2011cited by this paper
• Tyrosine phosphatases Shp1 and Shp2 have unique and opposing roles in oligodendrocyte development

  2010cited by this paper
• Control of oligodendrocyte generation and proliferation by Shp2 protein tyrosine phosphatase

  2010cited by this paper
• SHP2在非小细胞肺癌中的表达及意义

  2010cited by this paper
• Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

  2010cited by this paper
• Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic β-cells

  2009cited by this paper
• Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and Transformation*

  2009cited by this paper
• mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes

  2008cited by this paper
• Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death

  2008cited by this paper
• SHP2 is up‐regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis

  2008cited by this paper
• Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells

  2008cited by this paper
• The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.

  2008cited by this paper
• Diabetes mellitus and risk of endometrial cancer: a meta-analysis

  2007cited by this paper
• Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition

  2007cited by this paper
• Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1.

  2006cited by this paper
• Shp2 Is Required for Protein Kinase C-dependent Phosphorylation of Serine 307 in Insulin Receptor Substrate-1*

  2005cited by this paper
• Glucose Regulates Insulin Mitogenic Effect by Modulating SHP-2 Activation and Localization in JAr Cells*

  2002cited by this paper
• Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance

  2002cited by this paper
• Thrombopoietin Induces Phosphoinositol 3-Kinase Activation through SHP2, Gab, and Insulin Receptor Substrate Proteins in BAF3 Cells and Primary Murine Megakaryocytes*

  2001cited by this paper
• Pancreatic cancer and diabetes.

  1994cited by this paper

• Expression and clinical significance of tyrosine phosphatase SHP2 in thyroid carcinoma.

  2015cites this paper
• Expression and clinical significance of tyrosine phosphatase SHP 2 in thyroid carcinoma

  2015cites this paper
• Molecular behavior of the aptamer HJ24 self-assembled on highly oriented pyrolytic graphite (HOPG)

  2015cites this paper